These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 23359197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The endothelial cell markers von Willebrand Factor (vWF), CD31 and CD34 are lost in glomerulonephritis and no longer correlate with the morphological indices of glomerular sclerosis, interstitial fibrosis, activity and chronicity.
    Gluhovschi C, Gluhovschi G, Potencz E, Herman D, Trandafirescu V, Petrica L, Velciov S, Bozdog G, Bob F, Vernic C, Cioca D.
    Folia Histochem Cytobiol; 2010 Jan; 48(2):230-6. PubMed ID: 20675279
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stem cell factor and crescentic glomerulonephritis.
    El Kossi MM, El Nahas AM.
    Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
    [Abstract] [Full Text] [Related]

  • 9. Tubular and interstitial lesions and mononuclear cell infiltration in primary forms of glomerulonephritis.
    Grcevska L, Polenaković M.
    Ren Fail; 1993 Apr; 15(4):485-93. PubMed ID: 8105517
    [Abstract] [Full Text] [Related]

  • 10. Local macrophage proliferation in human glomerulonephritis.
    Yang N, Isbel NM, Nikolic-Paterson DJ, Li Y, Ye R, Atkins RC, Lan HY.
    Kidney Int; 1998 Jul; 54(1):143-51. PubMed ID: 9648072
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Myofibroblasts and the progression of crescentic glomerulonephritis.
    Goumenos D, Tsomi K, Iatrou C, Oldroyd S, Sungur A, Papaioannides D, Moustakas G, Ziroyannis P, Mountokalakis T, El Nahas AM.
    Nephrol Dial Transplant; 1998 Jul; 13(7):1652-61. PubMed ID: 9681707
    [Abstract] [Full Text] [Related]

  • 14. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis.
    Jinde K, Nikolic-Paterson DJ, Huang XR, Sakai H, Kurokawa K, Atkins RC, Lan HY.
    Am J Kidney Dis; 2001 Oct; 38(4):761-9. PubMed ID: 11576879
    [Abstract] [Full Text] [Related]

  • 15. The incidence of biopsy-proven primary glomerulonephritis in the Republic of Macedonia-long-term follow-up.
    Polenakovic MH, Grcevska L, Dzikova S.
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v26-7. PubMed ID: 12817063
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U, Aschoff A, Pocock J, Fünfstück R, Jirikowski G, Stein G, Wolf G.
    Nephron Clin Pract; 2007 Jul; 105(1):c18-28. PubMed ID: 17114899
    [Abstract] [Full Text] [Related]

  • 18. Immunohistochemical analysis of the interstitial mast cells in rebiopsied patients with idiopathic mesangial proliferative glomerulonephritis.
    Danilewicz M, Wagrowska-Danilewicz M.
    Pol J Pathol; 2005 Jul; 56(2):63-8. PubMed ID: 16092667
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.